NO20084140L - DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2. - Google Patents

DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2.

Info

Publication number
NO20084140L
NO20084140L NO20084140A NO20084140A NO20084140L NO 20084140 L NO20084140 L NO 20084140L NO 20084140 A NO20084140 A NO 20084140A NO 20084140 A NO20084140 A NO 20084140A NO 20084140 L NO20084140 L NO 20084140L
Authority
NO
Norway
Prior art keywords
rap
isoform
analogue
isolating
fragment
Prior art date
Application number
NO20084140A
Other languages
English (en)
Norwegian (no)
Inventor
David Wallach
Andrei Kovalenko
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12375898A external-priority patent/IL123758A0/xx
Priority claimed from IL12602498A external-priority patent/IL126024A0/xx
Publication of NO20084140L publication Critical patent/NO20084140L/no
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20084140A 1998-03-19 2008-10-01 DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2. NO20084140L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12375898A IL123758A0 (en) 1998-03-19 1998-03-19 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
IL12602498A IL126024A0 (en) 1998-03-19 1998-09-01 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
PCT/IL1999/000158 WO1999047672A1 (fr) 1998-03-19 1999-03-18 Modulateurs de la fonction de recepteurs de la famille des recepteurs tnf/ngf et d'autres proteines

Publications (1)

Publication Number Publication Date
NO20084140L true NO20084140L (no) 2000-10-30

Family

ID=40020126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084140A NO20084140L (no) 1998-03-19 2008-10-01 DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2.

Country Status (9)

Country Link
US (1) US20040219615A1 (fr)
EP (1) EP1454985A3 (fr)
JP (1) JP2009148285A (fr)
KR (1) KR100693677B1 (fr)
AR (1) AR015247A1 (fr)
EE (1) EE200900055A (fr)
NO (1) NO20084140L (fr)
PL (1) PL199214B1 (fr)
SG (1) SG148025A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025941A1 (fr) * 1995-02-22 1996-08-29 Yeda Research And Development Co. Ltd. Modulateurs de proteines regulatoires
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
EE200900055A (et) 2009-10-15
JP2009148285A (ja) 2009-07-09
KR20010034563A (ko) 2001-04-25
AR015247A1 (es) 2001-04-18
EP1454985A2 (fr) 2004-09-08
EP1454985A3 (fr) 2004-12-01
US20040219615A1 (en) 2004-11-04
KR100693677B1 (ko) 2007-03-09
SG148025A1 (en) 2008-12-31
PL199214B1 (pl) 2008-08-29

Similar Documents

Publication Publication Date Title
NO20014584L (no) Proteinisolering og -analyse
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
DE69739105D1 (de) Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DK0927192T3 (da) Modificerede aminosyrer, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
AR028315A2 (es) Compuestos de 1-arilpirazolcarboxaldehidos hidrazonas de plagas de actividad sistemica en la represion de plagas de artropodos, helmintos, nematodoss y protozoos; procedimientos para prepararlos y composiciones plaguicidas que lo contienen, y metodos de aplicacion de dichos compuestos para la repres
EP0585257A4 (fr) Adn et sequence d'acide amine specifiques de cellules tueuses k naturelles.
NO951861L (no) ECK-reseptorligander
FI962247A7 (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
EE200000151A (et) Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
PT84089B (pt) Sequencias de adn codificando para proteinas possuindo a actividade biologica dos inibidores de husi-tipo i, processos biotecnologicos para a preparacao das referidas proteinas e de composicoes farmaceuticas contendo as referidas proteinas
WO2002048403A3 (fr) Bioanalyse d'expression et d'activite de proteines multiples
DK1082423T3 (da) Cyclin E2-gener og -proteiner
GB9816514D0 (en) Novel method
NO20084140L (no) DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2.
WO2003106650A3 (fr) Acides nucleiques codant pour chd5, polypeptides, anticorps et procedes d'utilisation associes
DE69840233D1 (de) Verfahren zur Identifizierung von an das Chaperonin CCT bindenden Substanzen
BG104769A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
BR0211130A (pt) Plantas transgênicas que expressam proteìnas de ligação da cobalamina
WO1999064861A3 (fr) Procede d'identification de composes antidepresseurs
NO20002832D0 (no) Humantyroidprotein ZSig45 og DNA som koder for dette
AU2003215179A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
AU4624997A (en) Nematode proteins, dna sequences coding therefor, their specific antibodies and their use in identifying nematicidal active substances

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application